Evaluation of ClearLLab Leukemia and Lymphoma Panels

Leukemia-Lymphoma Clinical Trial

Official title:
Evaluation of ClearLLab Leukemia and Lymphoma Panels

Status Completed

Clinical Trial Summary

Multi-center study of specimens from subjects presenting to the flow cytometry laboratory as part of their standard of care for hematological diseases work-up.

Clinical Trial Description

Multi-center study of specimens from subjects presenting for flow cytometry immunophenotyping as part of their standard of care for hematological diseases work-up. Residual specimens will be tested using the ClearLLab Panels to determine the presence or absence of an abnormal phenotype and compare results to clinical impression (hematological malignancy or non-malignancy). ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03413644
Study type	Observational
Source	Beckman Coulter, Inc.
Contact
Status	Completed
Phase
Start date	November 14, 2017
Completion date	April 27, 2018

View Details

See also
	Status	Clinical Trial	Phase
	Completed	`NCT01464047` - Korean Post-marketing Surveillance for Sprycel®	N/A
	Completed	`NCT04003012` - Pain Control in Pediatric Oncology: Utility of EMLA Cream vs Lidocaine Injection in Lumbar Punctures	Phase 4